載入...
L-T4 Therapy in Enteric Malabsorptive Disorders
Levothyroxine (L-T4) absorption can be impaired by various causes: a) L-T4 ingestion during breakfast, or with food; b) conditions of reduced gastric acidity; c) intestinal procedures and diseases such as bariatric surgery, lactose intolerance (LI), celiac disease (CD), inflammatory bowel disease; d...
Na minha lista:
| 發表在: | Front Endocrinol (Lausanne) |
|---|---|
| Main Authors: | , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Frontiers Media S.A.
2021
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7940821/ https://ncbi.nlm.nih.gov/pubmed/33708175 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fendo.2021.626371 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|